| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |